Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform
Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...
KLA Corporation (KLAC) Faces Short-Term Headwinds in Semiconductor Equipment Market, Cantor Fitzgerald Sees Recovery in 2025
Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...
Cantor Fitzgerald Forecasts AVITA Medical FY2025 Earnings
Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of AVITA Medical in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn forecasts that ...